Clinical Trial Update: A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy [Phase 2]

View source ↗

Summary

This Phase II trial of the epothilone analog BMS-247550 in patients with non-small cell lung cancer after failure of first-line platinum-based chemotherapy has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BMS-247550 (epothilone analog) (BMS-247550)

Snippet

Sponsor: R-Pharm | Conditions: Carcinoma, Non-small-cell Lung | Phase 2 | Status: COMPLETED